Session (CTI)

ISSUE: Internationally, there is a growing drive to integrate patient preference information (PPI) into Health Technology Assessment (HTA) decision-making, reflecting a shift towards more diverse and inclusive forms of evidence. However, it is unclear how PPI is used in real-world contexts and the extent to which it can reshape and influence HTA decisions. Understanding how PPI can be meaningfully used in HTA is fundamental for supporting its practical application and increasing trust in the use of PPI. This panel session aims to enhance understanding of how HTA committees interpret and incorporate PPI into decision-making. OVERVIEW: The panel will present key findings from mock deliberation workshops conducted by members of the HTAi Patient Preference Project Subcommittee with experts from four HTA agencies. For the workshops, a mock evidence package was developed including PPI together with clinical and economic evidence to simulate decision-making processes in a mock deliberation to understand how decision-makers might use PPI. The findings highlight the importance of standardizing the path to integration as well as the content and format of PPI to support consistent interpretation and application in HTA. The panel will include a PPI researcher and representatives from patient advocacy (patient with lived experience) and HTA. An overview of results from the mock deliberations will be provided by the PPI researcher and the moderator (approximately 15 minutes). The moderator will summarize the mock scenario from the workshops (i.e., key clinical, economic, and PPI evidence), enabling the audience to participate in a mini-voting session. By examining how PPI is weighed alongside clinical and economic evidence, the issue panel session will discuss and provide valuable insights for stakeholders aiming to generate more pertinent PPI to be incorporated into the decision-making process and will provide key takeaways for HTA agencies interested in balancing this evidence in their assessments.